MOR Wealth Management’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$481K Hold
33,000
– – 0.18% 76
2026
Q2
$259K Hold
33,000
– – 0.1% 109
2026
Q1
$115K Hold
33,000
– – 0.05% 102
2025
Q4
$113K Buy
+33,000
New +$147K 0.05% 104

Other funds holding ABCL

MOR Wealth Management's ABCL Position: Q3 2026 in Review

MOR Wealth Management held its AbCellera Biologics (ABCL) position steady in Q3 2026 at 33,000 shares worth $481K. The position accounts for 0.18% of the portfolio, ranked #76.

MOR Wealth Management first reported a position in ABCL in Q4 2025 and has held it in 4 quarters since. 164 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.

  • MOR Wealth Management held 33,000 shares of AbCellera Biologics worth $481K as of Q3 2026.
  • MOR Wealth Management left its AbCellera Biologics share count unchanged in Q3 2026.
  • AbCellera Biologics made up 0.18% of MOR Wealth Management's portfolio in Q3 2026, its #76 holding.
  • MOR Wealth Management first reported a position in AbCellera Biologics in Q4 2025 and has held it in 4 quarters since.
  • 164 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.

Based on MOR Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.